Gliosarcoma
📧 Sign up to get email alerts when something new happens for Gliosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: Dose-Intense Temozolomide in Recurrent Glioblastoma [Phase 2]
Phase 2 trial assessing a dose-intensive temozolomide regimen in patients with recurrent glioblastoma and gliosarcoma; results were posted i…
-
CLINICAL_TRIALS trial_result · 2014-02-21Clinical Trial Update: Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma [Phase 2]
A phase 2 trial evaluating chemotherapy and radiation therapy after surgery in children with newly diagnosed astrocytoma, glioblastoma multi…
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma [Phase 1]
Phase 1 study evaluating the safety and potential activity of bevacizumab plus cediranib in patients with metastatic or unresectable solid t…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma [Phase 2]
A Phase II study evaluating bevacizumab (Avastin) with bortezomib for recurrent malignant glioma has completed and posted results, involving…
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas [Phase 1]
This is a completed Phase I trial evaluating an oral combination of topotecan and temozolomide for malignant gliomas, including glioblastoma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]
This is a Phase 2 trial update reporting on cediranib (AZD2171) in adults with recurrent glioblastoma multiforme and related brain tumors; t…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme [Phase 2]
Phase 2 study evaluating bevacizumab (Avastin) in combination with temozolomide and irinotecan for unresectable, multifocal glioblastoma mul…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors [Phase 2]
A Phase 2 clinical trial evaluating the combination of erlotinib and temozolomide with radiation therapy in adults with glioblastoma and rel…
-
CLINICAL_TRIALS trial_result · 2013-07-26Clinical Trial Update: Ph II Bevacizumab + Etoposide for Pts w Recurrent MG [Phase 2]
Phase II study evaluating bevacizumab plus etoposide in patients with recurrent malignant glioma (glioblastoma and gliosarcoma) completed; r…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating CCI-779 in patients with recurrent glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating gefitinib for newly diagnosed glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 clinical trial evaluating vorinostat for progressive or recurrent glioblastoma multiforme has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 trial evaluating the combination of vorinostat and bortezomib in adults with progressive or recurrent glioblastoma multiforme; the…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas [Phase 1]
A Phase I study of temozolomide combined with O6-benzylguanine and irinotecan in patients with recurrent or progressive cerebral anaplastic …
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma [Phase 2]
A Phase 2 clinical trial evaluating ritonavir and lopinavir for progressive or recurrent high-grade glioma was terminated, with results post…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme [Phase 1]
This document reports the completion of a Phase 1 trial evaluating radiation therapy with gadolinium texaphyrin for supratentorial glioblast…
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma [Phase 2]
Phase 2 trial of erlotinib in recurrent glioblastoma multiforme or gliosarcoma was terminated. Results were posted in May 2013.
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma [Phase 1, Phase 2]
This document reports the completed Phase 1/2 trial investigating motexafin gadolinium in combination with temozolomide and radiation therap…
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG) [Phase 2]
This document reports the completed Phase II trial results for bevacizumab plus erlotinib in patients with recurrent malignant glioma, inclu…
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma [Phase 2]
Phase 2 clinical trial evaluating bevacizumab with irinotecan or temozolomide for recurrent or refractory glioblastoma multiforme or gliosar…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1]
Phase 1 study evaluating the combination of temsirolimus, temozolomide, and radiation therapy in newly diagnosed glioblastoma; the trial sta…
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating tipifarnib with radiation therapy for newly diagnosed glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma [Phase 1]
Phase 1 trial evaluating arsenic trioxide with radiation therapy in newly diagnosed malignant glioma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme [Phase 2]
Phase II trial of erlotinib plus sirolimus in recurrent malignant glioma (glioblastoma and gliosarcoma) has completed and results were poste…
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG) [Phase 2]
Phase II study of imatinib plus hydroxyurea in patients with recurrent or progressive grade II low-grade glioma; trial completed with result…